-
1h 9sPart 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines
-
1h 1m 38s
-
1h 1m 4sPart 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease
-
1h 1m 28sPart 2 | Session 10 Plenary Session 12: Managing the patient with worsening and advanced HF
-
1h 1m 14s
-
1h 22sPart 1 | Session 3 Plenary Session 2: Managing your HF patients with comorbidities (part 1)
-
1h 1m 19sPart 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations
-
53m 32sPart 1 | Session 8 Plenary Session 4: Managing your HF patients with comorbidities (part 2)
-
1h 2m 37sPart 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs
-
37m 5sPart 1 | Session 12 Meet the expert: Sex differences in advanced heart failure
-
1h 1m 4sPart 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF
-
1h 2m 46sPart 2 | Session 1 Plenary Session 7: New technologies to manage your patients
e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Faculty Biographies
Fadi Jouhra
Personal History
Dr. Jouhra is based in London, where he works in the Department of Cardiology of St George’s University Hospital NHS Foundation Trust.
Academic History
Dr. Jouhra began his cardiology training at King’s College Hospital in Oct 2011 as a Locum Appointment Trainee for 1 year. During that year, he developed a specialist interest in heart failure and went on to secure a further 2-year fellowship with a focus on this topic at King's. He obtained a cardiology NTN in the Kent Surrey & Sussex Deanery in 2014 and then went on to train at Princess Royal Haywards Heath Hospital and Eastbourne District General Hospital.
Dr. Jouhra spent his first subspecialty year in Heart Failure and Devices at St George’s Hospital London. His second subspecialty year was at St Thomas’ Hospital where he was independently implanting complex devices including CRTs.2
…
Marat Fudim
Assistant Professor
Dr Marat Fudim is a cardiologist, advanced heart failure specialist and assistant professor at Duke University, Durham, US. He has a clinical and research interest in heart failure, including advanced therapies such as mechanical assist devices or "heart pumps" and heart transplantation.
As part of his work, Dr Fudim also performs cardiac catheterizations to understand a patient’s disease.
William T Abraham
Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.
His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair.
Prof Abraham has authored more than 1,000 original works and has been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds.
He received the 2017 Distinguished Scientist Award from the American College of Cardiology.
With his permission, Prof Abraham is contactable here.
